Senate Fails to Save Obamacare Subsidies; Premiums Will Soar
Over 20 million Americans face sharply higher health insurance costs after the Senate rejected both Republican and Democratic plans to extend expiring Affordable Care Act tax credits.
/ 907 items
#Healthcare↓
PetMed Shares Surge on $4 Buyout Proposal from SilverCape Investments
PetMed stock jumps after revealing a $4-per-share take-private proposal from SilverCape Investments. The board is reviewing the unsolicited offer amid years of declining performance.
Biohaven's BHV-1510 Shows 100% Response Rate in Endometrial Cancer Trial
Biohaven's (BHVN) BHV-1510 cancer drug shows impressive response rates in lung, endometrial, and bladder cancers with fewer side effects than similar treatments.
Promising New Treatment Shows Early Success for Prader-Willi Syndrome
Rhythm Pharmaceuticals (RYTM) announces positive results from Phase 2 trial of setmelanotide for Prader-Willi syndrome, showing BMI reduction and decreased hunger in patients.
Rezolute's Rare Disease Drug Fails to Beat Placebo in Key Trial
Rezolute's ersodetug therapy for congenital hyperinsulinism failed Phase 3 trial, missing primary endpoints. Stock plunged 90% as the drug showed no significant advantage over placebo.
Eli Lilly's Groundbreaking Obesity Drug Shows Record-Breaking Weight Loss Results
Eli Lilly's experimental retatrutide helps patients lose up to 24% body weight in trials, setting new standards for obesity treatment but with notable side effects and dropout rates.